🔗 Share this article

Chancellor Reeves has announced she is planning "focused action to address cost of living issues" in the forthcoming financial statement.

In comments to media outlets, she noted that curbing inflation is a joint responsibility of both the government and the Bank of England.

The UK's price growth is expected to be the highest among the Group of Seven advanced economies this year and the following year.

Potential Energy Bill Interventions

It is understood the government could intervene to lower utility costs, such as by reducing the current 5% rate of VAT applied on energy.

Another approach is to cut some of the regulatory levies currently added to bills.

Fiscal Limitations and Analyst Expectations

The administration will receive the next report from the official forecaster, the Office for Budget Responsibility, on the start of the week, which will reveal how much scope there is for such actions.

The consensus from the majority of experts is that the Chancellor will have to announce tax rises or expenditure reductions in order to meet her declared debt limits.

Earlier on the same day, calculations showed there was a twenty-two billion pound deficit for the Treasury chief to fill, which is at the more modest range of forecasts.

"It is a shared responsibility between the central bank and the government to further reduce some of the drivers of price increases," Reeves stated to reporters in Washington, at the yearly gatherings of the IMF and World Bank.

Tax Commitments and Global Issues

While much of the attention has been on likely tax increases, the chancellor said the latest data from the OBR had not changed her commitment to campaign commitments not to raise tax levels on earnings tax, sales tax or social security contributions.

She attributed an "unpredictable world" with growing geopolitical and commercial issues for the fiscal tax moves, probably to be directed on those "wealthiest."

International Economic Disputes

Referring to apprehensions about the United Kingdom's trade ties with China she said: "The UK's national security always are paramount."

Recent statement by China to increase export controls on critical minerals and other materials that are key for advanced tech production led American leader Donald Trump to threaten an further 100% tariff on goods from the Asian country, raising the prospect of an all-out commercial conflict between the two economic giants.

The US Treasury Secretary called China's action "commercial pressure" and "a international production control attempt."

Questioned on considering the American proposal to participate in its conflict with China, the Chancellor said she was "very concerned" by Chinese actions and urged the Beijing authorities "not to put up barriers and limit trade."

She said the decision was "damaging for the global economy and generates further obstacles."

"I believe there are areas where we must confront China, but there are also valuable prospects to export to Chinese markets, including banking sector and other areas of the economy. We've got to maintain that balance right."

The Treasury chief also affirmed she was working with G7 counterparts "on our own essential resources plan, so that we are more independent."

Health Service Medicine Pricing and Investment

The Chancellor also admitted that the price the NHS pays for medicines could rise as a result of current negotiations with the Trump administration and its pharmaceutical firms, in exchange for reduced taxes and funding.

A number of the biggest global drug companies have said recently that they are either delaying or canceling operations in the United Kingdom, with some attributing the low prices they are receiving.

Last month, the government science advisor said the cost the NHS spends on drugs would need to go up to stop firms and pharmaceutical investment leaving the United Kingdom.

The Chancellor stated to the BBC: "We have seen as a result of the cost structure, that drug testing, new drugs have not been offered in the UK in the manner that they are in other European countries."

"The objective is to ensure that people getting care from the NHS are can access the best critical drugs in the world. And so we are looking at all of that, and... seeking to obtain more funding into the UK."